76 assets in T-Cell Acute Lymphoblastic Leukemia

Therapeutic assets addressing T-Cell Acute Lymphoblastic Leukemia, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Vincristine Sulfate T-Cell Acute Lymphoblastic Leukemia	Children's Oncology Group	P3	BB (67)
Crisantaspase T-Cell Acute Lymphoblastic Leukemia	University of Washington	P3	BB (66)
Daunomycin T-Cell Acute Lymphoblastic Leukemia	SWOG Cancer Research Network	P3	BB (66)
Mercaptopurine Anhydrous T-Cell Acute Lymphoblastic Leukemia	SWOG Cancer Research Network	P3	BB (66)
Pegaspargase T-Cell Acute Lymphoblastic Leukemia	Children's Oncology Group	P3	BB (66)
Adriamycin T-Cell Acute Lymphoblastic Leukemia	SWOG Cancer Research Network	P3	BB (65)
Cytarabine T-Cell Acute Lymphoblastic Leukemia	SWOG Cancer Research Network	P3	BB (65)
Prednisone T-Cell Acute Lymphoblastic Leukemia	Children's Oncology Group	P3	BB (65)
Bortezomib T-Cell Acute Lymphoblastic Leukemia	Children's Oncology Group	P2/3	BB (64)
Cyclophosphamide T-Cell Acute Lymphoblastic Leukemia	SWOG Cancer Research Network	P3	BB (64)
Dexasone T-Cell Acute Lymphoblastic Leukemia	SWOG Cancer Research Network	P3	BB (64)
Methotrexate T-Cell Acute Lymphoblastic Leukemia	SWOG Cancer Research Network	P3	BB (64)
Rituximab T-Cell Acute Lymphoblastic Leukemia	University of Washington	P2	BB (64)
Thioguanine Anhydrous T-Cell Acute Lymphoblastic Leukemia	SWOG Cancer Research Network	P3	BB (64)
Asparaginase T-Cell Acute Lymphoblastic Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P3	B (63)
Calaspargase Pegol T-Cell Acute Lymphoblastic Leukemia	SWOG Cancer Research Network	P3	B (63)
Nivestim T-Cell Acute Lymphoblastic Leukemia	Children's Oncology Group	P3	B (63)
Venetoclax T-Cell Acute Lymphoblastic Leukemia	M.D. Anderson Cancer Center	P2	B (63)
Daratumumab T-Cell Acute Lymphoblastic Leukemia	Children's Oncology Group	P2/3	B (62)
Decitabine T-Cell Acute Lymphoblastic Leukemia	M.D. Anderson Cancer Center	P3	B (62)
Hydrocortisone T-Cell Acute Lymphoblastic Leukemia	Children's Oncology Group	P3	B (62)
Prednisolone T-Cell Acute Lymphoblastic Leukemia	Children's Oncology Group	P3	B (62)
Etoposide T-Cell Acute Lymphoblastic Leukemia	University of Washington	P3	B (61)
Nelarabine T-Cell Acute Lymphoblastic Leukemia	Children's Oncology Group	P3	B (61)
Pegfilgrastim T-Cell Acute Lymphoblastic Leukemia	University of Washington	P2	B (60)
Imatinib T-Cell Acute Lymphoblastic Leukemia	University of Washington	P3	B (59)
(+)-Vincristine T-Cell Acute Lymphoblastic Leukemia	SWOG Cancer Research Network	P2	B (59)
Wu-Cart-007 T-Cell Acute Lymphoblastic Leukemia	Wugen, Inc.	P2	B (58)
Azacitidine T-Cell Acute Lymphoblastic Leukemia	yuejun Liu	P2	B (57)
Dexrazoxane T-Cell Acute Lymphoblastic Leukemia	Children's Oncology Group	P3	CCC (54)
Isocyclophosphamide T-Cell Acute Lymphoblastic Leukemia	Children's Oncology Group	P3	CCC (54)
Levofolinic Acid T-Cell Acute Lymphoblastic Leukemia	Children's Oncology Group	P3	CCC (54)
Mesna T-Cell Acute Lymphoblastic Leukemia	M.D. Anderson Cancer Center	P1/2	CCC (54)
Blinatumomab T-Cell Acute Lymphoblastic Leukemia	SWOG Cancer Research Network	P2	CCC (53)
Dasatinib T-Cell Acute Lymphoblastic Leukemia	St. Jude Children's Research Hospital	P2	CCC (53)
Hyaluronidase T-Cell Acute Lymphoblastic Leukemia	Eastern Cooperative Oncology Group	P2	CCC (53)
Isatuximab T-Cell Acute Lymphoblastic Leukemia	Goethe University	P2	CCC (53)
Nadravaleucel T-Cell Acute Lymphoblastic Leukemia	Federal Research Institute of Pediatric Hematology, Oncology and Immunology	P2	CCC (53)
Navitoclax T-Cell Acute Lymphoblastic Leukemia	National Cancer Institute (NCI)	P2	CCC (51)
Revumenib T-Cell Acute Lymphoblastic Leukemia	SWOG Cancer Research Network	P2	CCC (51)
cd5-targeted car-t cells T-Cell Acute Lymphoblastic Leukemia	Zhejiang University	P1	CCC (50)
cd7.car/28zeta car t cells T-Cell Acute Lymphoblastic Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P1/2	CCC (50)
cd7-specific car gene-engineered t cells T-Cell Acute Lymphoblastic Leukemia	Shenzhen Geno-Immune Medical Institute	P1/2	CCC (50)
Cpx-351 T-Cell Acute Lymphoblastic Leukemia	Children's Oncology Group	P1/2	CCC (48)
ctd402 car t cell T-Cell Acute Lymphoblastic Leukemia	BIOHENG THERAPEUTICS US LLC	P1/2	CCC (48)
Imgn632 T-Cell Acute Lymphoblastic Leukemia	Children's Oncology Group	P1/2	CCC (48)
Obi 3424 T-Cell Acute Lymphoblastic Leukemia	SWOG Cancer Research Network	P1/2	CCC (48)
Autologous Bcma/Cd19 Dual-Target Car-T Module T-Cell Acute Lymphoblastic Leukemia	Beijing Biotech	P1/2	CC (45)
Autologous Bcma/Cd38 Dual-Target Car-T Module T-Cell Acute Lymphoblastic Leukemia	Beijing Biotech	P1/2	CC (45)
Autologous Bcma/Gprc5D Dual-Target Car-T T-Cell Acute Lymphoblastic Leukemia	Beijing Biotech	P1/2	CC (45)

Showing 1 to 50 of 76 assets

PreviousPage 1 of 2Next